Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)
China · Delayed Price · Currency is CNY 7.46
-0.12 (-1.58%)
Jun 11, 2026, 3:04 PM CST
SHE:300534 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 49.37 | 43.95 | 24.48 | 61.65 | 38.79 | -9.11 |
Depreciation & Amortization | 43.16 | 43.16 | 38.5 | 29.9 | 26.99 | 22.56 |
Other Amortization | 1.44 | 1.44 | 0.3 | 0.06 | 0.02 | - |
Loss (Gain) From Sale of Assets | 0.01 | 0.01 | 0.69 | 0.24 | - | -0.07 |
Asset Writedown & Restructuring Costs | - | - | - | - | 0.1 | 4.79 |
Loss (Gain) From Sale of Investments | -0.8 | -0.8 | -0.39 | - | -0.91 | -0.8 |
Provision & Write-off of Bad Debts | 7.47 | 7.47 | -4.17 | 8.9 | 5.28 | 1.14 |
Other Operating Activities | 56.51 | 25.54 | 30.9 | 26.23 | 10.66 | 3.73 |
Change in Accounts Receivable | -14.53 | -14.53 | 62.91 | 2.59 | -68.12 | 34.53 |
Change in Inventory | -1.86 | -1.86 | -18.59 | -11.65 | 19.62 | -12.79 |
Change in Accounts Payable | -109.6 | -109.6 | 79.99 | -20.1 | 235.47 | 8.28 |
Change in Other Net Operating Assets | - | - | - | - | -0.65 | -1.12 |
Operating Cash Flow | 29.85 | -6.54 | 214.92 | 96.53 | 267.44 | 51.13 |
Operating Cash Flow Growth | -40.55% | - | 122.65% | -63.91% | 423.01% | 17.55% |
Capital Expenditures | -44.61 | -43.36 | -77.69 | -126.36 | -25.41 | -0.41 |
Sale of Property, Plant & Equipment | 0 | 0 | - | - | - | 0.01 |
Investment in Securities | - | - | - | - | 15 | - |
Other Investing Activities | 0.8 | 0.8 | 0.6 | - | -14.09 | 0.8 |
Investing Cash Flow | -43.81 | -42.56 | -77.09 | -126.36 | -24.5 | 0.4 |
Long-Term Debt Issued | - | 35.54 | 21.82 | 142 | - | - |
Total Debt Issued | 34.27 | 35.54 | 21.82 | 142 | - | - |
Long-Term Debt Repaid | - | -19.39 | -97.79 | -3.11 | -20 | -70.07 |
Total Debt Repaid | -15.71 | -19.39 | -97.79 | -3.11 | -20 | -70.07 |
Net Debt Issued (Repaid) | 18.56 | 16.15 | -75.97 | 138.89 | -20 | -70.07 |
Issuance of Common Stock | - | 1 | 6 | - | - | - |
Common Dividends Paid | -4.09 | -14.83 | -15.57 | -3.82 | -0.49 | - |
Other Financing Activities | -13.62 | -22.2 | -42.1 | -185.79 | 1.32 | -0.53 |
Financing Cash Flow | -26.57 | -19.88 | -127.64 | -50.72 | -19.17 | -70.6 |
Net Cash Flow | -40.53 | -68.98 | 10.19 | -80.55 | 223.77 | -19.07 |
Free Cash Flow | -14.76 | -49.9 | 137.23 | -29.83 | 242.03 | 50.72 |
Free Cash Flow Growth | - | - | - | - | 377.18% | 103.30% |
Free Cash Flow Margin | -1.75% | -5.63% | 13.16% | -2.76% | 30.27% | 17.62% |
Free Cash Flow Per Share | -0.05 | -0.17 | 0.45 | -0.10 | 0.80 | 0.17 |
Cash Interest Paid | - | - | - | - | - | 0.53 |
Cash Income Tax Paid | 103.58 | 133.44 | 155.64 | 135.24 | 58.17 | 20.13 |
Levered Free Cash Flow | -67.44 | -49.67 | 91.87 | -47.68 | 226.77 | 56.23 |
Unlevered Free Cash Flow | -65.78 | -48.01 | 93.97 | -45.22 | 227.07 | 56.56 |
Change in Working Capital | -127.31 | -127.31 | 124.62 | -30.45 | 186.52 | 28.89 |